26/05/2026
Japan bans CBN on June 1 — and the gap between Japan and the rest of the world just got wider.
Starting June 1, 2026, cannabinol (CBN) becomes a "designated drug" (指定薬物) here in Japan. Manufacture, import, sale, use — all banned. The only door left open is a narrow medical channel for patients with intractable conditions who can navigate the MHLW approval process. Everyone else: if you've got CBN gummies, oils, cookies, vapes, or tinctures sitting at home, you've got until June 1 to dispose of them. After that, possession is illegal.
The Ministry of Health, Labour and Welfare is justifying this on the grounds of "high likelihood of psychotoxicity." Let's be honest about what CBN actually is. It's a mildly active cannabinoid that forms naturally when THC degrades — essentially aged cannabis. People around the world use it for sleep, relaxation, and mild pain relief. It is not getting anyone high. It is not filling emergency rooms. Japan's own industry coalition, the Japan Cannabinoid Federation, formally pointed out that the psychoactive effects are extremely weak, and that CBN already occurs in trace amounts in many CBD products sitting legally on Japanese shelves right now.
Now look around the rest of the world.
Canada became the first G7 country to commercially legalize cannabis in 2018. Germany decriminalized possession and opened home cultivation in 2024. The Czech Republic joined them on January 1, 2026 — adults over 21 can now legally grow up to three cannabis plants and possess up to 100 grams. Malta, Luxembourg, South Africa — all moving in the same direction. Medical cannabis is legal in Argentina, Australia, Brazil, Croatia, Denmark, Germany, Greece, Ireland, Israel, Italy, the Netherlands, New Zealand, Poland, Portugal, Switzerland, the UK, Uruguay — and that's not even a full list. Nearly 50 countries have legalized cannabis to some degree, and regulated adult-use markets now serve roughly 230 million people, most of them in the United States, Canada, and Uruguay. Thailand, right next door, decriminalized in 2022.
Meanwhile, Japan is over here banning a sleep aid that California grandmothers buy at the corner store.
And it isn't just CBN. The pattern repeats every time. HHC banned. THCH banned. HHCH banned in late 2023. Every time a new cannabinoid shows up in the wellness market, MHLW reaches for the designated drug classification and shuts it down before any serious evidence base develops. The THC threshold for legal CBD here is essentially zero — vastly stricter than the 0.2% or 0.3% standard used across most of Europe and the U.S. Cannabis possession itself still carries years of prison time and a level of social ruin that simply doesn't exist in most developed countries.
And the economic damage from this latest ban is real. According to interviews with retail operators in the sector, CBN products accounted for at least a third of all cannabinoid sales in Japan. That's not a niche product disappearing — that's a third of an entire industry's revenue evaporating overnight. Small businesses that built inventory, hired staff, and signed leases on the assumption of a legal market are now scrambling to liquidate stock before June 1 or write it off entirely. Online retailers are pulling listings. Importers who placed orders months ago are eating the losses. And this is the third major rug-pull in three years — HHC, HHCH, now CBN. No investor, no entrepreneur, no responsible operator can plan a multi-year business in this environment. Compare that to Germany, where the cannabis sector is generating thousands of jobs and serious tax revenue, or Canada's multi-billion-dollar regulated market, or even Thailand's messy but very real boom. Japan is choosing to leave that money, those jobs, and that innovation on the table — and then wondering why young entrepreneurs are giving up.
The medical cannabis reform Japan passed in late 2023 was sold as a breakthrough. In practice it opened the door for a tiny handful of pharmaceutical products like Epidiolex for severe epilepsy. That's it. No flower, no broad-spectrum oils, no real medical program of the kind a German, Australian, or Israeli patient takes for granted.
So here we are. Patients in Germany are picking up cannabis flower at the pharmacy on a prescription. Adults in Canada are walking into licensed stores and buying gummies. Czechs are growing three plants in the kitchen window. And in Japan, a non-intoxicating cannabinoid that people use to sleep better is being treated like a designer drug threat. The official framing is "protecting public health." The reality is a regulatory culture that hasn't caught up to a generation of science, and an industry that gets suffocated every time it finds new legal ground to stand on.
If you're currently using CBN — dispose of it before June 1. CBD with zero THC stays legal, so that's the obvious switch for anyone using it for sleep or relaxation. But the bigger question this country has to start asking, and one we've been asking on this page for a while, is how long Japan can keep pretending the rest of the world is wrong.
Drop your thoughts below. What's been your experience with CBN, and what are you planning to do after the ban?
